Estudo randomizado | Eficácia, segurança e imunogenicidade da vacina de DNA contra SARS-CoV-2 (ZyCoV-D).
6 Abr, 2022 | 12:48hComentário convidado: DNA vaccines join the fight against COVID-19 – The Lancet
Comentário no Twitter
DNA-based #COVID19 vaccine, ZyCoV-D, demonstrates efficacy, safety, and immunogenicity, according to interim analysis of phase 3 trial conducted in India.
More: https://t.co/bI2eXdbOvB pic.twitter.com/tMuHrA1kz6
— The Lancet (@TheLancet) April 2, 2022